White House nears deal to lower costs for popular weight loss drugs

Drug Pricing & Accessibility - The White House is reportedly nearing a deal with drug manufacturers to lower the costs of certain drugs [1] - The Trump administration is preparing to announce a deal to sell WGO and Zepbound for as little as $149 per month for the lowest doses [2] - The deal may include limited coverage for some Medicare patients [2] - Medicaid recipients could potentially be covered under the deal [3] Specific Drugs & Manufacturers - The deal surrounds two drugs: Zepbound and Wakovi [1] - Drug makers Eli Lilly and Novo Nordisk are in discussions with the administration [3] - Eli Lilly is reportedly asking the White House to speed up FDA approval of its weight loss pill [3] Cost Perspective - The typical cost of these drugs can reach well over $1,000 per month [4] - The $149 price represents a significant discount [3][4] - These drugs are typically taken every month, leading to substantial cumulative costs [4]